Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

5,330 companies

Ticker	Company	Revenue	Net income	Net margin ▴	Return on equity	Revenue growth	Diluted EPS
PMHS	Polomar Health Services, Inc. Manufacturing · Year ended 2025-12-31 · USD	$648.2K	-$10.70M	n/m	n/a	n/m	-$0.39
PMN	ProMIS Neurosciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.72M	n/a	n/a	n/a	-$22.61
PMTR	Perimeter Acquisition Corp. I Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	n/a	n/a	n/a	n/a	n/a
PMVC	PMV Consumer Acquisition Corp. Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	-$154.1K	n/a	-49.6%	n/a	n/a
PMVP	PMV Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.74M	n/a	-74.2%	n/a	-$1.48
PNBK	Patriot National Bancorp Inc Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	-$12.71M	n/a	-13.4%	n/a	-$0.17
PNFP	Pinnacle Financial Partners, Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	$641.87M	n/a	9.1%	n/a	$8.07
PNNT	PennantPark Investment Corp Year ended 2025-09-30 · USD	n/a	$32.73M	n/a	7.1%	n/a	n/a
POLE	Andretti Acquisition Corp. II Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	$8.35M	n/a	n/a	n/a	n/a
POSC	Positron Corp Manufacturing · Year ended 2025-12-31 · USD	$461.5K	-$10.60M	n/m	-734.4%	-21.5%	-$0.34
PPCB	Propanc Biopharma, Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$18.86M	n/a	-200.6%	n/a	-$17.62
PPLT	abrdn Platinum ETF Trust Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	$1.34B	n/a	46.9%	n/a	n/a
PPTA	Perpetua Resources Corp. Mining · Year ended 2025-12-31 · USD	n/a	-$100.39M	n/a	-11.7%	n/a	-$1.08
PRAX	Praxis Precision Medicines, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$303.27M	n/a	-34.5%	-100.0%	-$13.48
PRFX	PRF Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$17.0K	-$5.02M	n/m	-58.8%	n/a	-$7.47
PRKR	Parkervision Inc Manufacturing · Year ended 2025-12-31 · USD	$0	-$7.43M	n/a	n/a	n/a	n/a
PRME	Prime Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.63M	-$201.14M	n/m	-166.4%	55.3%	-$1.35
PROK	Prokidney Corp. Manufacturing · Year ended 2025-12-31 · USD	$893.0K	-$151.61M	n/m	n/a	n/m	n/a
PROV	Provident Financial Holdings Inc Finance & Real Estate · Year ended 2026-06-30 · USD	n/a	$6.66M	n/a	5.3%	n/a	$1.03
PRTA	Prothena Corp Public Ltd Co Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$244.09M	n/m	-87.0%	-92.8%	-$4.53
PSBD	Palmer Square Capital BDC Inc. Year ended 2025-12-31 · USD	n/a	-$3.17M	n/a	-0.7%	n/a	$1.66
PSEC	Prospect Capital Corp Year ended 2026-06-30 · USD	n/a	$153.66M	n/a	5.2%	n/a	$0.06
PTIX	Protagenic Therapeutics, Inc.\new Manufacturing · Year ended 2026-03-31 · USD	n/a	$1.37M	n/a	52.2%	n/a	$0.59
PTOR	Praetorian Acquisition Corp. Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	n/a	n/a	n/a	n/a	n/a
PTPI	Petros Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$1.91M	n/a	66.7%	n/a	-$1.56

Rows per page: 2550 100